SonoScape Medical Corp.

SZSE:300633.SZ

45.25 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q1
Revenue 533.357474.99652.419424.493570.309473.031511.36415.76464.9370.629504.468297.397360.946281.786450.813226.128251.856234.284464.161245.182314.591229.92434.138252.213309.644230.854350.827214.483263.936159.823325.152135.896163.5794.739130.722
Cost of Revenue 183.168146.687189.46135.466175.1148.528142.565150.844142.817147.815150.999.167114.666106.473137.19773.93893.32285.814164.46594.99297.91977.899136.26766.319101.82765.183115.10465.83582.75949.595110.79445.00261.05934.97145.665
Gross Profit 350.19328.303462.959289.027395.209324.502368.795264.916322.082222.814353.569198.23246.28175.314313.616152.19158.534148.47299.696150.19216.672152.021297.871185.895207.817165.671235.723148.648181.177110.227214.35890.893102.51159.76885.057
Gross Profit Ratio 0.6570.6910.710.6810.6930.6860.7210.6370.6930.6010.7010.6670.6820.6220.6960.6730.6290.6340.6460.6130.6890.6610.6860.7370.6710.7180.6720.6930.6860.690.6590.6690.6270.6310.651
Reseach & Development Expenses 110.542101.638120.63793.82389.78680.0186.285.67381.38375.70270.80865.72866.96559.55758.30362.56157.36759.18982.00554.71861.66556.52568.91262.85652.6249.098220.26254.61378.9870133.797058.645021.71
General & Administrative Expenses -18.28734.546-58.03671.462-11.71425.153-46.7458.446-5.67617.477-37.65150.384-5.29519.312-34.40218.823-6.6918.66-29.60620.025-6.76317.656-17.7113.384-49.88959.438-146.00866.367-36.60748.974-95.19138.28738.67234.50929.36
Selling & Marketing Expenses 164.381122.907171.614121.246125.823105.682137.75499.289112.75573.365103.43697.79193.19272.10995.29682.0116087.072138.42396.01591.44280.998124.24574.41775.33978.23196.22461.74565.64845.4776.92645.36941.61433.14445.652
SG&A 146.094165.109113.578192.708114.109130.83591.015157.735107.07990.84365.785148.17587.89691.42160.894100.83453.311105.732108.817116.03984.6898.654106.53587.80125.45137.67-49.784128.11329.04194.444-18.26583.65680.28767.65275.011
Other Expenses 0.870.503-1.7517.188-17.735-0.252-3.0080.091-0.394-0.05938.783-0.8940.692-0.06-1.567-0.019-0.293-0.0260.4240.8980.162-0.025-0.196-0.5540.1840.003-16.0610.0321.5494.46520.34918.9368.87513.1674.241
Operating Expenses 280.85266.747318.404227.511236.816180.548235.852186.386199.086149.27186.234173.839163.902130.254158.719149.232118.15144.995233.697160.486151.966133.929201.385136.835111.075131.888131.136112.165109.087100.19143.19284.83482.62168.75178.36
Operating Income 65.77561.556125.07958.618141.689149.428116.6381.105128.4856.21373.76526.34274.3441.217-77.3032.4539.399-8.71833.659-11.60468.69415.86778.32160.193109.18424.02994.16935.0470.3158.15462.7342.76720.638-6.9322.589
Operating Income Ratio 0.1230.130.1920.1380.2480.3160.2280.1950.2760.1520.1460.0890.2060.146-0.1710.0110.156-0.0370.073-0.0470.2180.0690.180.2390.3530.1040.2680.1630.2660.0510.1930.020.126-0.0730.02
Total Other Income Expenses Net -0.68149.981-0.185-0.5570.01-0.252-0.1240.023-0.326-0.05938.809-0.2570.054-0.06-0.029-0.019-0.293-0.0260.2320.898-0.029-0.025-0.005-0.5540.1840.003-16.0610.0321.5494.46520.34918.9368.87513.1674.24
Income Before Tax 65.095111.537124.89558.06141.699149.176116.50681.128128.15456.154112.57426.08574.39441.157-77.3322.43139.106-8.74333.892-10.70668.66415.84278.31659.639109.36824.03178.1145.07271.86312.61983.08421.70329.5146.2356.829
Income Before Tax Ratio 0.1220.2350.1910.1370.2480.3150.2280.1950.2760.1520.2230.0880.2060.146-0.1720.0110.155-0.0370.073-0.0440.2180.0690.180.2360.3530.1040.2230.210.2720.0790.2560.160.180.0660.052
Income Tax Expense -5.28811.346-8.92610.5037.11410.702-7.90610.5644.3955.0774.689-4.2261.4775.026-4.2060.7745.644-0.489-4.108-1.8028.2873.777-3.9057.18812.3423.1052.9293.8758.2822.5555.6772.0632.491-0.122-2.161
Net Income 70.383100.191133.8247.557134.585138.474124.41170.565123.75951.077107.88530.31172.91736.132-73.1261.65733.461-8.25537.999-8.90460.37712.06482.22152.45197.02620.92675.1841.19763.58110.06577.40619.6427.0236.3578.99
Net Income Ratio 0.1320.2110.2050.1120.2360.2930.2430.170.2660.1380.2140.1020.2020.128-0.1620.0070.133-0.0350.082-0.0360.1920.0520.1890.2080.3130.0910.2140.1920.2410.0630.2380.1450.1650.0670.069
EPS 0.160.230.310.110.310.320.290.160.290.120.270.0760.180.09-0.190.0040.085-0.020.09-0.0220.150.030.20.130.240.0520.190.10.160.0280.210.0550.0750.0180.02
EPS Diluted 0.160.230.310.110.310.320.290.160.290.120.270.0760.180.09-0.190.0040.085-0.020.09-0.0220.150.030.20.130.240.0520.190.10.160.0280.210.0550.0750.0180.02
EBITDA 83.67119.921147.65372.688167.909154.68141.97795.308137.30372.907206.5626.16682.450.827149.8963.55345.53810.61972.554-0.22471.96115.21894.14163.58101.8840.276103.25239.03377.8711.227143.1117.19620.751-10.27910.265
EBITDA Ratio 0.1570.2520.2260.1710.2940.3270.2780.2290.2950.1970.4090.0880.2280.180.3330.0160.1810.0450.156-0.0010.2290.0660.2170.2520.3290.1740.2940.1820.2950.070.440.1270.127-0.1080.079